Roivios Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A
  • (Cancelled)

  • Latest Deal Amount
  • $36M

  • Investors
  • 1

Roivios General Information

Description

Developer of a patented technology intended to re-establish the pressure gradient necessary for kidney function. The company's lead product, JuxtaFlow (R), includes an endoscopically placed catheter set designed to deliver a mild suction (negative pressure) into the renal pelvis, enabling medical practitioners to offer treatment to simultaneously improve renal function and decrease venous congestion for fluid-overloaded patients.

Contact Information

Website
www.roivios.com
Formerly Known As
Strataca Systems
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • Albany Financial Center
  • Suite 708, South Ocean Boulevard
  • Albany, New Providence
  • Bahamas
+1 (678) 000-0000

Roivios Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roivios Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 29-Jul-2022 $36M Cancelled Clinical Trials - General
3. Later Stage VC 01-Oct-2021 00.00 000.00 Completed Clinical Trials - General
2. Later Stage VC 18-Aug-2020 $10.5M $25M Completed Clinical Trials - General
1. Seed Round 01-Aug-2018 $14.5M $14.5M Completed Startup
To view Roivios’s complete valuation and funding history, request access »

Roivios Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a patented technology intended to re-establish the pressure gradient necessary for kidney function. The com
Therapeutic Devices
Albany, Bahamas
2 As of 2023
000.00
00000000000

000000

is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
00000000000 0000000
Kadima, Israel
00 As of 0000
00000
00000000000 00000

000000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
00000000000 0000000
Galway, Ireland
00 As of 0000
0000
0000000000 0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Roivios Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Magenta Medical Venture Capital-Backed Kadima, Israel 00 00000 00000000000 00000
0000000000 Venture Capital-Backed Galway, Ireland 00 0000 0000000000 0 0000
000000000 Corporation Winston-Salem, NC 00 00000 000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

Roivios Patents

  • 144

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 19

    Granted

  • 10

    Pending

  • 000

    Expiring in next 12 mo

Roivios Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230364322-A1 Wearable garment for negative pressure therapy Pending 10-May-2022 000000000
US-20210370019-A1 Method of treatment using negative pressure renal therapy and medicament(s) Pending 28-May-2020 0000000000 0
EP-3958918-A1 Pump assembly and system for inducing negative pressure in a portion of a urinary tract of a patient Pending 23-Apr-2019 00000000
AU-2020261384-A1 Pump assembly and system for inducing negative pressure in a portion of a urinary tract of a patient Pending 23-Apr-2019 00000000
CA-3138967-A1 Pump assembly and system for inducing negative pressure in a portion of a urinary tract of a patient Pending 23-Apr-2019 A61M1/82
To view Roivios’s complete patent history, request access »

Roivios Executive Team (4)

Name Title Board Seat Contact Info
John Erbey Ph.D Chief Executive Officer
Malcolm St. John Chief Financial Officer
You’re viewing 2 of 4 executive team members. Get the full list »

Roivios Board Members (1)

Name Representing Role Since
E Elaine Erbey Self Chairman 000 0000
To view Roivios’s complete board members history, request access »

Roivios Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Roivios Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Crown Capital (Atlanta) PE/Buyout Minority 000 0000 000000 0
To view Roivios’s complete investors history, request access »

Ready to get started?

Request a free trial